Mind Medicine (MindMed)
Stock Forecast, Prediction & Price Target
Mind Medicine (MindMed) Financial Estimates
Mind Medicine (MindMed) Revenue Estimates
Mind Medicine (MindMed) EBITDA Estimates
Mind Medicine (MindMed) Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $29.95M Low: $29.95M High: $29.95M avg. 0% | Avg: $53.03M Low: $53.03M High: $53.03M avg. 77.04% | Avg: $215.32M Low: $215.32M High: $215.32M avg. 306.01% |
Net Income
% change YoY
| $-93.03M N/A | $-47.26M 49.20% | $-95.73M -102.56% | Avg: $-105.51M Low: $-62.65M High: $-45.42M avg. -10.22% | Avg: $-124.37M Low: $-69.70M High: $-42.68M avg. -17.87% | Avg: $-48.35M Low: $-48.35M High: $-48.35M avg. 61.11% | Avg: $1.43M Low: $1.43M High: $1.43M avg. 102.96% |
EBITDA
% change YoY
| $-93.74M N/A | $-74.36M 20.67% | $-92.57M -24.47% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$3.4 N/A | -$1.53 54.99% | -$2.44 -59.47% | Avg: -$1.41 Low: -$1.6 High: -$1.16 avg. 42.09% | Avg: -$1.5 Low: -$1.78 High: -$1.09 avg. -5.96% | Avg: -$1.24 Low: -$1.24 High: -$1.24 avg. 17.50% | Avg: $0.04 Low: $0.04 High: $0.04 avg. 102.96% |
Operating Expenses
% change YoY
| $93.85M N/A | $66.33M -29.32% | $93.86M 41.51% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Mind Medicine (MindMed) stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 33.99% in 2025-2028.
We have gathered data from 5 analysts. Their low estimate is -62.65M, average is -105.51M and high is -45.42M.
What is Mind Medicine (MindMed) stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 95.76% in 2025-2028.
We have gathered data from 7 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.
What is Mind Medicine (MindMed) stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 39.15% in 2025-2028.
We have gathered data from 5 analysts. Their low earnings per share estimate is -$1.6, average is -$1.41 and high is $-1.16.
What is the best performing analyst?
In the last twelve months analysts have been covering Mind Medicine (MindMed) stock. The most successful analyst is Brian Abrahams.